Tumour‐infiltrating lymphocytes in ductal carcinoma <i>in situ</i> (DCIS)—assessment with three different methodologies and correlation with Oncotype DX DCIS Score
Miglena K. Komforti(Albert Einstein College of Medicine), Susan Fineberg(Albert Einstein College of Medicine), Sunil Badve(Emory University), Bryan Harmon(Albert Einstein College of Medicine), Yungtai Lo(Albert Einstein College of Medicine)
Cited by 10
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
|Journal of Clinical Oncology|2014|1.3k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2010|898